Cmed announces it joins the AIXIAL Group, part of ALTEN, and continues to expand its global reach and service offering. This very synergistic combination enables Cmed to support its valued customers by creating a unique, fully integrated Technology-led CRO offering an end-to-end partner.
Cmed is Where Technology Meets Expertise. No other CRO is better prepared to support Biotech and Biopharma sponsors deliver the future of clinical trials.
Technology-led and with speciality expertise in oncology, cell & gene therapy, rare diseases, data science and analytics, we pioneered the processes for delivering next generation trials.
As the global pharmaceutical industry continues to undergo seismic change, our 20 years of innovation, commitment and expertise enable us to embrace radical disruption and transform the clinical trials landscape for the benefit of patients.
We anticipate. We adapt. We embrace every challenge. We are where you want to be.